Literature DB >> 21526652

Hepatitis C virus antibody status, sociodemographic characteristics, and risk behaviour among injecting drug users in Croatia.

Tatjana Vilibić Cavlek1, Jelena Marić, Ljiljana Katicić, Branko Kolarić.   

Abstract

The study was conducted among 76 injecting drug users (IDU) from seven Croatian cities during a three-year period (2005-2007). Each participant completed a questionnaire on sociodemographic characteristics and potential risk factors for hepatitis C virurs (HCV) infection followed by anti-HCV and anti-HIV antibody testing. The mean patient age was 30. The majority of patients (69.8%) reported more than one potential exposure to HCV: 97.1% had shared injecting equipment, 75% reported risk sexual behaviour, and 56.3% reported a history of travelling abroad. The overall HCV seroprevalence was 51.3% (95% CI = 40-63%). HCV seroprevalence increased with increasing number of risk behaviours (p = 0.026). Needle sharing frequency was the most important risk factor for hepatitis C. The HCV seroprevalence rate ranged from 27.3% in IDUs who answered that they shared needles occasionally to 100% in IDUs who always shared needles (p < 0.001). No other risk factors (age, gender, educational level, marital and employment status, history of travelling abroad and sexual risk behaviour) were associated with HCV seropositivity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21526652     DOI: 10.21101/cejph.a3602

Source DB:  PubMed          Journal:  Cent Eur J Public Health        ISSN: 1210-7778            Impact factor:   1.163


  2 in total

Review 1.  Epidemiology of hepatitis C in Croatia in the European context.

Authors:  Tatjana Vilibic-Cavlek; Jasmina Kucinar; Bernard Kaic; Maja Vilibic; Nenad Pandak; Ljubo Barbic; Vladimir Stevanovic; Jasmina Vranes
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

2.  Prevalence of HIV and other infections and correlates of needle and syringe sharing among people who inject drugs in Podgorica, Montenegro: a respondent-driven sampling survey.

Authors:  Dragan Lausevic; Senad Begic; Boban Mugosa; Natasa Terzic; Zoran Vratnica; Itana Labovic; Ivana Bozicevic
Journal:  Harm Reduct J       Date:  2015-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.